⌘K

Login Start Free

Home/Filings/4/0000899243-20-017882

4//SEC Filing

Lamb Damian 4

Accession 0000899243-20-017882

CIK 0001805890other

View on SEC.gov Company Profile

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 6:45 AM ET

Size

5.3 KB

Accession

0000899243-20-017882

Insider Transaction Report

Form 4

Period: 2020-06-25

Fusion Pharmaceuticals Inc.FUSN

Director

Transactions

Award
Stock Option (Right to Buy)
2020-06-25+30,000→ 30,000 total
Exercise: $17.00Exp: 2030-06-18→ Common Shares (30,000 underlying)

Footnotes (1)

[F1]This option shall vest and become exercisable in 36 equal monthly installments commencing on July 18, 2020.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Fusion Pharmaceuticals Inc.

CIK 0001805890

Entity typeother

Related Parties

1

filerCIK 0001814032

Filing Metadata

Form type: 4
Filed: Jun 29, 8:00 PM ET
Accepted: Jun 30, 6:45 AM ET
Size: 5.3 KB

View on SEC.gov